BioMedNewsBreaks Archive - Page 164 of 195

ThursdayJan 07, 2021 10:14 am

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Releases Disposable Pediatric EEG Headset

Earlier this month, Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, announced that its proprietary NeuroCap(TM) would be available for pediatric patients in the United States. The company noted that the child-sized EEG headset reduces the time typically needed to measure and mark a pediatric patient’s head, as well as for post-test sanitation protocols; the company also observed that the pediatric-sized NeuroCap, designed for use with children aged 2 to 18, could be used in emergency rooms, intensive care units and clinics. A recent “Health Insider” article explained that EEG tests can be required to investigate seizures, sleep…

ThursdayJan 07, 2021 9:45 am

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at the H.C. Wainwright BioConnect 2021 Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its CEO, John Climaco, will present at the virtual H.C. Wainwright BioConnect 2021 Conference. The event is slated to be held from Jan. 11-14, 2021, with Climaco’s presentation scheduled for 6:00 a.m. ET on the first day of the event. Interested parties should visit https://ibn.fm/09lxu to register. The webcast will be available on demand starting at 6:00 a.m. ET on Monday, Jan. 11, 2021. Replays of the presentation will be available…

WednesdayJan 06, 2021 12:22 pm

BioMedNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics Completes QM CoRE(TM) Integration

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that its wholly owned subsidiary Helomics has completed the integration of Quantitative Medicine’s (“QM”) novel active-learning Computational Research Engine (CoRE(TM)). According to the update, CoRE was integrated with Helomics’ proprietary TumorSpace(TM) knowledgebase of 150,000 tumor drug response profiles and the TruTumor(TM) patient primary tumor cell line assay. The move allows Helomics to offer a revolutionary new AI-driven patient-centric drug discovery service to pharmaceutical companies that will significantly improve the chances of successfully translating new drugs into the clinic. “With…

WednesdayJan 06, 2021 10:50 am

BioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Announces Participation in Two Upcoming Virtual Events

LexaGene Holdings (TSX.V: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, will be presenting at two investor conferences in January: the SNN Network Canada Virtual Event and the H.C. Wainwright Bioconnect 2021 Virtual Conference. Company founder and CEO Dr. Jack Regan will represent LexaGene at both events. The SNN Network Canada Virtual Event is scheduled for Thursday, Jan. 7, 2021; LexaGene’s live presentation is slated to begin at 1:30 p.m. ET. Those interested can find the webcast presentation on the conference event platform under the agenda tab following the event. The H.C. Wainwright Bioconnect…

WednesdayJan 06, 2021 10:43 am

BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) to Participate in H.C. Wainwright BioConnect Virtual Conference

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced that it will participate in the virtual H.C. Wainwright BioConnect Conference taking place on Jan. 11-14, 2021. According to the update, AzurRx BioPharma president and CEO James Sapirstein will take part in virtual one-on-one meetings with registered investors and pharmaceutical companies. Sapirstein will be available to provide an overview of the company’s business and clinical development programs, as well as discuss anticipated 2021 milestones. Interested parties should visit https://ibn.fm/bNYP3 to register for the event. To view the full press release, visit…

WednesdayJan 06, 2021 9:31 am

BioMedNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at Upcoming H.C. Wainwright Bioconnect Conference

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company with its lead indication in phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, on Tuesday announced that it will present at the H.C. Wainwright Bioconnect 2021 Conference. According to the update, the presentation will be available on-demand throughout the event from Jan. 11-14, 2021, starting at 6:00 a.m. ET. In addition, a webcast of the presentation will be available via the IR section of the company’s website and will be archived and accessible for at least 90 days. To view…

WednesdayJan 06, 2021 8:30 am

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Launches Proprietary Technology for Obstructive Sleep Apnea Treatment

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea, announced its commercial launch of AireO2(TM). AireO2 is a new patient-management software technology designed to assist health-care providers to diagnose, treat and monitor patients with obstructive sleep apnea (“OSA”) and its related conditions. With an estimated 1 billion people suffering from OSA around the world, it is the most predominant diseases, and can cause life-threatening high blood pressure, heart failure, stroke and other health problems. and life-threatening diseases. “We believe that Vivos’ sleep-specific AireO2 patient…

TuesdayJan 05, 2021 2:02 pm

BioMedNewsBreaks – United Medical Equipment Business Solutions Network Inc.’s App Assists with Well-Informed Decisions

United Medical Equipment (“UME”) has created a powerful app designed for health-care professionals, caregivers, students and family members who are providing direct and indirect patient care and education. Providing critical information and access to real-time tools, UME’s Medication Management app features more than a dozen different functionalities. The app enables access to a library for up-to-date information on medications and their indications, dosage, side effects, etc.; identification tools for medications not contained in original packaging; conversion systems for metric-U.S./Imperial quantities that includes weight, temperature, volume, and height; dosage converter for active medications/treatments; and much more. A recent article discussing this…

TuesdayJan 05, 2021 12:42 pm

BioMedNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Featured in Equity Research Report

INmune Bio (NASDAQ: INMB), a biotechnology company focused on modulating components of the innate immune system to treat cancers and chronic neurological diseases, was featured in an equity research report by Quantum Media Group LLC. Quantum announced its coverage initiative on INmune Bio on Dec. 30, 2020, and provided details on its research paper that discusses the paradigm shift in Alzheimer’s research and treatment strategies in development, rejecting the decades-long approach by the pharmaceutical industry and academia at large. Quantum believes that INmune Bio’s XPro1595 is potentially a best-in-class Alzheimer’s drug, and further believes that the readout for the upcoming…

TuesdayJan 05, 2021 11:30 am

BioMedNewsBreaks – Predictive Oncology (NASDAQ: POAI) Engages Investor Relations Firm

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that it has hired an investor relations firm. POAI has chosen Landon Capital to provide investor relations services; the agreement was effective Dec. 30, 2020. The announcement noted that anticipated services would include introductions to investors, financial and industry analysts, registered brokers and financial writers. Those introductions would be made with the intent to provide interested individuals and groups with information about POAI’s business strategy, developments and accomplishments. The announcement also noted that Landon Capital would assist POAI in the…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

BioMedNewsBreaks

BioMedNewsBreaks – Brain Scientific Inc. (BRSF) Releases Disposable Pediatric EEG Headset

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at the H.C. Wainwright BioConnect 2021 Conference

BioMedNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics Completes QM CoRE(TM) Integration

BioMedNewsBreaks – LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Announces Participation in Two Upcoming Virtual Events

BioMedNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) to Participate in H.C. Wainwright BioConnect Virtual Conference

BioMedNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at Upcoming H.C. Wainwright Bioconnect Conference

BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Launches Proprietary Technology for Obstructive Sleep Apnea Treatment

BioMedNewsBreaks – United Medical Equipment Business Solutions Network Inc.’s App Assists with Well-Informed Decisions

BioMedNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Featured in Equity Research Report

BioMedNewsBreaks – Predictive Oncology (NASDAQ: POAI) Engages Investor Relations Firm

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search